American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 2(63), 2019
DOI: 10.1128/aac.01393-18
Full text: Download
Dihydroartemisinin-piperaquine (DHA-PQ) is under study for intermittent preventive treatment during pregnancy (IPTp), but it may accelerate selection for drug resistance. Understanding the relationships between piperaquine concentration, prevention of parasitemia, and selection for decreased drug sensitivity can inform control policies and optimization of DHA-PQ dosing.